Bringing Down the Cost of Prescription Drugs August 30, 2019 11:03
It was Tuesday when U.S. Rep. Anthony Brindisi received petitions with more than 3,500 signatures from people throughout New York’s 22nd Congressional District.
Each petitioner is seeking the same thing: Action from Congress to lower the cost of prescription drugs.
Message received, Brindisi said Wednesday at a forum to discuss and address concerns on drug costs.
Brindisi said he thinks there is no bigger issue in his district than the cost of prescription drugs. Though, when it comes to Congress lowering those costs, he believes the ball now is in the Senate’s court.
“There’s a lot of talk about bipartisanship down in Washington,” he said. “The one area that I see a silver lining, in terms of bringing Democrats and Republicans together, is to do something about the high cost of prescription drugs.”
Roughly 20 people attended the forum on the library’s second floor where Brindisi spoke.
Brindisi said there is bipartisan support for legislation that already has passed the House of Representatives.
“I know if you turn on the TV sometimes and the national news, you think nothing’s happening,” Brindisi said. “Well, guess what? Things are happening in the House, and they’re happening especially when it comes to protecting our health care and trying to lower our drug costs.”
Such solutions include allowing Medicare to negotiate prescription prices, instituting a cap on out-of-pocket costs and improving access to lower-cost generic drugs.
“If you compare us to other nations, we pay the highest costs in the world,” Stelling said. “It’s a pain point. We know for our members and many other Americans, they’re making tough choices, which means either putting food on the table or getting the medicine they need. Either one is a sacrifice to your health.”
After remarks from Stelling and Brindisi, the two fielded questions from the audience mostly related to the prescription drug issue. Here are a few of them with Brindisi’s responses:
Can Congress institute a cap on prescription drug costs?
“This is something that many countries do have: A cap on prescription drugs, and I think it’s something we should look at in this country, as well, because when you’re talking about ... having to take $30,000 every few months for cancer medication, if you’re uninsured, I don’t know how you do that. We should look at how we implement caps. Not stifling research; obviously, a lot of pharmaceutical companies are doing life-saving research and development ... but we should be looking at what’s reasonable and what we can do to put some caps in place to try and prevent exorbitant costs that we’re seeing.”
How likely is the Senate to pass the bills?
“I think there is a very strong chance of getting some of these bills through the Senate.”
Brindisi cited the ability for other countries to negotiate drug prices, cost caps on certain medications in other countries, and one he called “the elephant in the room.”
“Money. The Bible says that the love of money is the root of all evil,” he said. “That is the same down in Washington.”
Do You Have Backup Insurance to Basic Medicare? You Should August 22, 2019 17:51
Experts have a message for anyone thinking about relying on basic Medicare with no extra coverage: Don’t do it.
Health Insurance for Seniors
Medicare Supplement Premiums Increase.... Now What? August 9, 2019 11:54
Some Medicare Supplement premiums are going up about 15 percent (check your insurer) beginning Sept. 1.
Exercise for Seniors
Review Your Medicare Advantage Program July 1, 2019 13:55
Open-enrollment for the Medicare Advantage Program begins in October. Tom and Scott want to help you prepare all of your information now that you need to enroll.
Stronger Seniors Chair Exercise Programs
What is the 'Senior' Flu Shot? October 5, 2017 14:07
Basically, it's a stronger flu shot. Four times stronger to be precise.
This flu vaccine could significantly reduce the risk of hospitalization among especially vulnerable seniors, a large, random clinical trial has found.
Vaccines typically don’t work very well in older people—a problem because the flu can lead to serious respiratory infections in frail patients such as elderly nursing home residents.
“…the rate of hospitalization for any reason, respiratory or otherwise, was significantly lower in the high-dose group…”
While a prior study showed that older individuals could respond better to the high-dose vaccine, it focused on relatively healthy older adults, says lead author Stefan Gravenstein, professor at both the Warren Alpert Medical School and the School of Public Health at Brown University.
It still needed to be established that it would help even the frailest folks, like those who reside in nursing homes.
In this study, a quarter of the sample was over 90. DId the high-dose vaccine also work better than regular-dose vaccine in the population we consider least able to respond. This paper says yes, it can.
The study compared hospitalization rates among more than 38,000 residents of 823 nursing homes in 38 states during the 2013-14 flu season based on Medicare claims data. Just under half the homes, 409 to be exact, administered the high-dose vaccine while the other 414 provided a standard dose.
In the end, the hospitalization rate for respiratory illnesses among high-dose patients was 3.4 percent compared to 3.8 percent among standard-dose patients over the six months after vaccination. Statistical analysis revealed that the relative risk of hospitalization for respiratory illness was 12.7 percent lower for the high-dose group.
Moreover, the rate of hospitalization for any reason, respiratory or otherwise, was significantly lower in the high-dose group as well. For every 69 people given the high-dose vaccine vs. the standard-dose vaccine, one more person stayed out of the hospital during the flu season.
“Respiratory illness as the primary reason for hospitalization accounted for only about a third of the reduction in hospitalization that we measured,” says Gravenstein.
For many patients, the vaccine appeared to help prevent hospitalization for other problems also, including cardiovascular symptoms.
Gravenstein says the finding of a significant reduction in hospitalizations was particularly notable because the predominant flu strain during the 2013-14 season, A/H1N1pdm, was believed to be less virulent in older people who had spent a long lifetime building up immunity to similar strains.
“That there was differential protection in this context both underlines the potential importance of even low-virulence or less transmissible strains to older populations and the fact that vaccines may afford relevant effectiveness among frail older persons even when A/H1N1 predominates,” the authors write.
The study did not find a significant difference in the rate of death. Researchers speculate that while the standard-dose vaccine might not have been strong enough to stave off illness entirely, it may still have been sufficient to prevent deaths in combination with hospital care.
But a significant reduction in hospitalizations can still be a benefit, Gravenstein says, even though the high-dose vaccine is more expensive than the standard-dose vaccine. Especially for older, frail patients, reducing otherwise necessary trips to the hospital can maintain a higher quality of life.
Ultimately, Gravenstein says, the study should provide nursing home leadership with useful information to consider as they plan for future flu seasons.
Here’s how to find a lower cost Medicare prescription drug plan. November 23, 2016 12:35
Seven Medicare Part D Costs to Prepare For...Switching plans might allow you to reduce your prescription drug costs.
Medicare Part D beneficiaries are eligible to change Medicare Part D plans each year between October 15 and December 7, and for most people it's worth considering a switch. Two-thirds of Part D plan enrollees are facing premium increases if they stay with their current plan in 2017, according to a Kaiser Family Foundation analysis of 2017 Medicare Part D plan offerings. But premium prices are only one aspect of selecting the Medicare Part D prescription drug plan that best meets your medication needs. Many other factors influence your out-of-pocket costs including the plan's formula of covered medications, deductible, co-pays, coinsurance and network of preferred pharmacies. Here are the costs you should consider as you select a Medicare Part D plan for next year.
Premiums. The average Medicare Part D premium will be $42.17 in 2017 if retirees stick with their current plan, according to KFF projections. That's a 62 percent increase from the average of $26.04 per month retirees paid in 2006, the year the Medicare Part D drug benefit was introduced. However, premiums vary widely among plans. Among the 10 plans with the highest enrollment, premiums range from $16.81 to $71.66 per month. Medicare beneficiaries have an average of 22 Medicare Part D plans to choose from, so most retirees have a variety of options to consider.
Deductibles. The standard Medicare Part D deductible will increase by $40 to $400 in 2017. The majority of Part D plans (62 percent) will charge a deductible in 2017. The standard deductible is the most common amount, but some plans have smaller deductibles or no deductible.
Copays and coinsurance. Most Part D plans have five tiers of covered medications with different cost-sharing requirements. There are typically two tiers for generic drugs, with small or no copayments for preferred generic drugs and slightly higher copays for medications on the non-preferred generic tier. The next tier is for preferred brand name drugs, which typically involves a $40 copayment in 2017, but a few plans charge 20 percent of the cost of the medication. The cost often jumps to 40 percent of the price of the medication for drugs on the non-preferred brand name tier. Most Part D plans also have a specialty medication tier for expensive drugs, and plans generally charge either 25 percent or 33 percent of the cost of the medicine. Enrollees usually pay higher out-of-pocket costs when plans pass on a percentage of the price of the drug to patients rather than a set copayment amount, KFF found.
The coverage gap. Medicare Part D has a coverage gap, which is often referred to as the donut hole. Retirees who spend enough money on prescription drugs to enter the coverage gap will need to pay for 40 percent of the cost of brand-name drugs and 51 percent of the price of generic drugs until their expenses are high enough for catastrophic coverage to kick in. Most Part D plans (72 percent) don't provide additional gap coverage beyond what is required, KFF found.
Out-of-network pharmacies. Most Part D plans (85 percent) have preferred pharmacies where retirees can fill their prescriptions at a lower cost, up from 7 percent in 2011. If you choose to use a different pharmacy, the out-of-pocket cost for the same medication is higher. For example, one plan charges a $1 copayment for preferred genetic drugs and $4 for non-preferred generic drugs at a preferred pharmacy, but those cost-sharing requirements climb to $10 and $20, respectively, at a non-preferred pharmacy.
Drugs that aren't in the formulator. Each Medicare Part D plan has a list of covered drugs called the formulator. You can check to see if your current medications, or medicines you expect to need in the coming year, are covered by each plan and at what price. Plans are allowed to change their formulator each year, so you will need to repeat this search annually. Some plans also place restrictions on certain drugs, such as limiting how much of a given medication you can buy at a time, requiring you to try a lower cost drug before the plan will pay for a higher cost alternative or requiring you to get prior authorization before you can fill certain prescriptions. Take a close look at the covered medications and the drug restrictions before purchasing a plan.
Late enrollment penalty. Most people first become eligible for Medicare Part D during the seven-month period that begins three months before the month they turn 65. It's important to sign up during this initial enrollment period, because a late enrollment penalty is permanently added to your Medicare Part D premiums if you go 63 or more days without prescription drug coverage after becoming eligible for Medicare Part D.
Source: Emily Brandon is the author of "Pensionless: The 10-Step Solution for a Stress-Free Retirement."